Value proposition

A “Software as a Medical Device” (SaMD) company developing proprietary AI-powered image analytics and predictive models.

At UMMON HealthTech, we envision a world where algorithms improve patient care worldwide through earlier, more accurate and more affordable cancer diagnosis.

By using AI and deep learning, we help Pathologists identify cancerous cells more accurately and earlier. Our platform provides end-to-end data-driven pathology analysis, resulting in fast, accurate and standardized pathologic diagnoses.

AI in Pathology
UMMON HealthTech has patented a proprietary AI-powered platform for pathology analysis. We are currently focusing on bringing to the market a “Software as a Medical Device” for the diagnosis of cervical cancers.

Diagnostic Software for Private Practice and Hospital
UMMON HealthTech is developing clinical decision support tools designed to improve the clinical workflow of private practice and hospital thanks to increased efficiency, standardization, and new clinical insights.
By bringing AI into private practice and hospital, we create new cost-saving opportunities without jeopardizing the quality in cancer diagnosis.

Global Access to Healthcare
UMMON HealthTech is working towards building AI solutions usable in emerging countries as well. By deploying our technology in areas that lack proper specialists, helping patients get diagnosed quickly with more accuracy, the goal of UMMON HealthTech is to make an enduring impact on patient care by helping hundreds of millions of people promptly receive reliable cancer diagnoses.